The quality analysis tools driving speed to market are now built right into the control system.
It is more important than ever for pharmaceutical manufacturers to deliver treatments quickly and cost-effectively around the globe. With the world’s new focus on rapid results, gone are the days when product could sit in work-in-progress (WIP) for days, weeks, or even months, waiting on lab testing for quality validation.
Plants are putting massive effort into digitally transforming operations to move toward level five of BioPhorum’s digital plant maturity model. As they move up the model, organizations realize lean manufacturing benefits while more quickly and safely putting critical treatments in the hands of patients in need (Figure 1).